Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › MA › Palmer › NPI 1265830764
NP / PA

Gurney, Rebecca

Gurney, Rebecca was paid $140K by Medicaid between Dec 2018 and Apr 2022, across 14 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 46% of everything it billed.

33Billing provider infoGURNEY, REBECCA
PALMER, MA 01069
33aNPI1265830764assigned 12/15/2014
28Total paid$140K
24GClaims3,157
24DCodes billed14
24AFirst – last monthDec 2018 – Apr 2022
Compared with peers

Next to other Family Nurse Practitioner providers in Massachusetts

Rank by total paid#28 of 327
Median peer was paid$5K
This provider vs. median26×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$5.0K$10K$15K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
201831$2K
2019792$35K
2020588$30K
20211,204$56K
2022542$17K
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99213 Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity 46% 1,149 1,117 $64K
99214 Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 19% 298 291 $27K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 15% 422 415 $21K
G2023 Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source 6.9% 423 416 $10K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe 4.7% 209 206 $7K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets 3.3% 61 61 $5K
90460 Immunization administration through 18 years of age via any route, first or only component 1.8% 60 60 $2K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 113 111 $1K
S0302 Completed early periodic screening diagnosis and treatment (epsdt) service (list in addition to code for appropriate evaluation and management service) <1% 133 133 $1K
96127 <1% 53 50 $682.96
87804 Infectious agent antigen detection by immunoassay; Influenza, each type <1% 37 36 $447.47
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward <1% 13 13 $412.21
2 more codes
96110 Developmental screening, with scoring and documentation, per standardized instrument <1% 26 $337.37
94760 <1% 160 $292.50

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.